STR has started a clinical trial in Europe for its ACL device and has successfully implanted the device in 7 patients as of October 2013. Their device utilizes a synthetic scaffold that regenerates the entire ligament tissue resulting in better chances of full recovery.
Profound’s unique device for Prostate cancer treatment is currently in Phase I clinical trials in Europe and Canada. Profound has also received FDA approval to conduct clinical trials in U.S that will begin soon in 2013. The company is on fast track to begin commercialization in Europe by 2015.
NEW YORK, Oct. 15, 2013 – OneMedForum announced today that a major theme of its 7th annual healthcare investing conference will be to provide investors with an outlook about how the healthcare system will function post-Obamacare. Moreover, it will also address the new financing opportunities created by the JOBS Act and feature innovatively growing companies that are best positioned to succeed in this new environment.
With the holidays approaching, we are reminded of the year that is now coming to a close. 2011 has brought some amazing advancements in the […]
OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as […]
OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as […]
Citigroup [NYSE:CITI] pricing GSVC’s $100 million raise this week. As of end of trading Sept 19th, GSVC stock is trading at about $14.37 and seems undervalued for several reasons.
The weather is cooling, but the health industry is heatings things up. OneMedSentinel is pleased to bring you another round of stories and interviews with […]
Global Silicon Valley Capital [NASDAQ: GSVC] announces a $7 million investment in Twitter and other tech stocks.
With this issue of the newly formatted Sentinel we are introducing OneMedRadio a product designed to bring our readers interviews with the CEOs and investors […]
Copyright © 2024 | WordPress Theme by MH Themes